EHC
Encompass Health CorpPrice & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| adjusted EBITDA growth non-GAAP | 11.2% | Q1 2026 call | — |
| adjusted free cash flow non-GAAP | $194M | Q1 2026 call | — |
| annualized RN turnover | 17.8% | Q1 2026 call | — |
| annualized therapist turnover | 6.4% | Q1 2026 call | — |
| contract labor FTEs as a percent of total FTEs | 1.2% | Q1 2026 call | — |
| discharge growth | 4.3% | Q1 2026 call | — |
| discharge to acute rate | 8.6% | Q1 2026 call | — |
| discharge to community rate | 84.5% | Q1 2026 call | — |
| discharge to SNF rate | 6.2% | Q1 2026 call | — |
| net leverage | 1.9 | Q1 2026 call | — |
| net pre-opening and ramp-up costs | $4M | Q1 2026 call | — |
| net revenue per discharge growth | 3.7% | Q1 2026 call | — |
| nurses on clinical ladder | 35% | Q1 2026 call | — |
| premium labor costs | $25.9M | Q1 2026 call | — |
| premium labor spend decline | 9.4% | Q1 2026 call | — |
| same-store discharge growth | 1.6% | Q1 2026 call | — |
| share repurchase amount | $71.6M | Q1 2026 call | — |
| shares repurchased | 708,000 | Q1 2026 call | — |
| SWB per FTE growth | 3.7% | Q1 2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EHC
this stock
Encompass Health Corp
|
$11.01B | +4.5% | +10.5% | 18.5 | 3.2% |
|
HCA
HCA Healthcare, Inc.
|
$90.73B | -11.9% | +7.1% | 14.1 | 2.4% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$27.28B | -14.9% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$17.81B | +3.8% | -2.3% | 10.8 | 4.7% |
|
DVA
Davita Inc.
|
$14.73B | +103.1% | +6.5% | 21.4 | 7.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EHC | +9.3% | +9.3% | +10.3% | +9.3% | +4.5% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +9.5% | +8.4% | +2.9% | +9.5% | -4.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.